Group items tagged

Northern Ireland will see changes in the regulatory landscape following the issuance of the Windsor Framework on 27th Feb 2023 and the corresponding EU Commission proposal. An agreement, in principle, has been reached by the UK and EU. The new path forward of the Windsor Framework marks a turning point in how both the UK and the EU will work together collaboratively and constructively to ensure that the same medicines are available in Northern Ireland at the same time as they are in the rest of the United Kingdom. Whilst this is a successful result for Northern Ireland patients, this is major change for companies that have made specific provisions in their supply chains for Northern Ireland. The supply chains of companies where provisions and changes were made such as introduction of GB specific pack may be impacted as a result. However, the burden on the UK Pharma supply chain will be eased. Prime Minister Rishi Sunak walks with European Commission chief Ursula von der Leyen in Windsor on February 27, 2023 Pharma companies will need to carefully consider making changes within their processes and supply chains pending the issuance of clear guidance from the MHRA on the regulation changes resulting from the Windsor Agreement and the corresponding EU Commission proposed regulatory changes associated with medicinal products within the Northern Ireland market. Smooth access to the EU market for Northern Ireland pharmaceutical and medical technology firms has been safeguarded within the constraints of the agreement. The pragmatic dual-regulatory system protects business, patients and healthcare services, and reflects that it is an essential state function to maintain and oversee the supply of medicines within the whole United Kingdom.

British drugmaker GSK has signed deals with three companies allowing them to make inexpensive generic versions of its long-acting HIV preventive medicine for use in lower-income countries, where the majority of new HIV cases occur. The injected drug cabotegravir is approved by regulators in Britain and the United States. Last July, GSK announced a program with the United Nations-backed healthcare organisation, the Medicines Patent Pool, aiming to get poor countries access to new HIV therapies far earlier than they did for previous HIV medicines. During the HIV/AIDs epidemic in Africa in the 1990s and early 2000s, in which many millions of people died, treatments used widely in wealthy countries were unavailable on the continent. GSK said last year the new program could result in the generic form of its injection being available in lower-income countries beginning in 2026. The drugmaker's HIV treatment division, ViiV Healthcare, said in a statement on Wednesday it had issued voluntary licenses - waiving intellectual property rights - to Aurobindo, Cipla and Viatris, which will manufacture the generic versions of injectable cabotegravir.

The World Health Organization (WHO) issued a warning on Thursday regarding falsified semaglutide medications used for treating type 2 diabetes and obesity in select countries. This WHO Medical Product Alert addresses three falsified batches of the specific brand Ozempic that were detected in Brazil (October 2023), the United Kingdom and Northern Ireland (October 2023), and the United States (December 2023). These falsified semaglutide products were distributed through the regulated supply chain. Novo Nordisk, the genuine manufacturer of Ozempic, confirmed that the three products mentioned in the alert are falsified and were not produced by the company. Healthcare professionals, regulatory authorities and the public are advised to remain vigilant regarding these falsified batches of medicines. Dr Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products, urged stakeholders to stop any usage of suspicious medicines and report them to relevant authorities.

Refurbished Carefusion Alaris Medley Module PCU 8000 Point-of-Care Unit is the core of the Alaris System, which provides a common user interface for programming the infusion and monitoring modules, helping to reduce complexity at the point of care.

Refurbished Carefusion Alaris Medley Module PCU 8000 Point-of-Care Unit is the core of the Alaris System, which provides a common user interface for programming the infusion and monitoring modules, helping to reduce complexity at the point of care.

FBR Staff Writer Published 05 January 2015 Cargill India is set to commence production at its INR5bn ($78.8m) maize milling unit in Karnataka in June 2015. Construction work on the maize plant is currently underway, reports fnbnews.com.

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka ...

GlaxoSmithKline Pharmaceuticals Ltd is investing Rs 1,000 crore in a new state-of-the-art pharmaceutical unit in Karnataka ...

NorthEast had to battle arduous against Pune, in a very match that saw 2 red cards, with Nirmal Chet...

Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year, as the Swiss drugmaker prepares to spin off its Sandoz generics business. Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion. Adjusted for overall negative currency effects, group sales in 2022 advanced 4 per cent to $50.5 billion as gains from heart failure drug Entresto and multiple sclerosis (MS) drug Kesimpta were partly offset by competition from cheap generic copies of established MS drug Gilenya. Novartis said it was on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its focus on its patented prescription medicines. Analysts have welcomed a programme unveiled in 2022 to trim costs and cut 8,000 jobs and plans to focus on fewer therapy areas and drug technologies. But the market has been underwhelmed by prospects for medium-term growth from new drugs.

The MHRA's Criminal Enforcement Unit (CEU), working with other law enforcement partners, has seized more than two million "illegally traded medicines" this year, with a total value of £5 million. The products confiscated in the UK were prescription-only medicines including anti-depressants, pain medication and human growth hormones. The MHRA launched an initiative, Operation Pangea, 15 years ago to combat "illegal internet trade in medical" products. Andy Morling, the Deputy Director of Criminal Enforcement of MHRA, spoke about Operation Pangea's 15-year anniversary. "Fifteen years ago, the MHRA started Operation Pangea, combining our knowledge and resources with those of international partners to disrupt and bring to justice the criminal gangs responsible for selling medicines illegally and causing harm around the world.

The tested amount of glucosamine and chondroitin area unit enclosed within the Triflex formula. May facilitate dieters affected by painful joints stand up and start moving.

Dentistry services at chicago. Includes child dental specialist, periodontist, gum disease, oral surgeon, dental implants, orthodontist in Chicago, Illinois, United States.

The Life Fitness 97Ti treadmill is built with only premium health club quality parts and it includes all of the features that reliable gym units maintain.

Dr. Michael Mullan is a holder of Licentiate in Medicine and Surgery of the Society of Apothecaries, United Kingdom. He completed his Medical Degree from London University.

Ankylosing spondylitis follows among the rheumatic diseases, this Ankylosing spondylitis diseases belongs to the group of Spondylarthropathy. Ankylosing spondylitis arthritis affected up to 2% of people in the United States and it affects more males than females. This disease mostly begins in between 20 to 40 old year's people.

Ear tubes are the #1 reason children get surgery or anesthesia in the United States. The tympanostomy tube placement guideline not only helps doctors and parents identify children likely to benefit most from surgery, but importantly identifies those for whom watchful waiting may be a better option.

Best Ultherapy & Laser Facial Service in Edwardsville and surrounding the area. Dr. Jacobs' passion for anti-aging treatments has led her to become the #1 injector of Botox and Juvederm in the Greater St. Louis Area, placing her in the top 1% of Allergan accounts in the United States.

Erectile Dysfunction (ED) is a complex problem with many different potential causes. More than 30 million men are suffering from erectile dysfunction in the United States alone.

Lenox Hill Hospital, where Beyonce Knowles gave birth to her baby daughter, has been cleared from complaints. Jeffrey Gordon, a spokesman for the New York State Health Department, said that the complaints patients in a hospital neonatal unit were mistreated during the R&B singer's stay were dismissed by Wednesday, January 11 night.

Sensa Product Reviews : If losing coefficient is so effortless, then how turn Americans are so over unit? The sign of adults age 20 and over who are weighty is 34%. The signaling of adults in the self age groups who are fleshiness is 34%. This is determined by the BMI (Embody Aggregation Indicant). That numerate gives us a enumerate of 68% of Americans who are confidential as 'fat deposits.' The conflict between fleshiness and weighty is in the BMI lottery. Stoutness is from 25 - 29.9 BMI and fat is any BMI over 30. The BMI is a determine of body fat supported on your unit and top. Below 25 is considered goodness. Let's juncture the fasting gyration and acquire to do is depression to regress and you can try it for slaveless.

Erectile Dysfunction (ED) is a complex problem with many different potential causes. More than 30 million men are suffering from erectile dysfunction in the United States alone. A very landmark study and research has revealed that the cause for Erectile Dysfunction may stem from Hypertension, diabetes, trauma, and many others